Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

Cannabidiol (CBD) as an Adjunctive Therapy in Schizophrenia: A Multicenter Randomized Controlled Trial

McGuire P. et al, (2018), American Journal of Psychiatry, 175, 225 - 231

Cannabidiol: Pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders

Devinsky O. et al, (2014), Epilepsia, 55, 791 - 802

Cannabinoids and schizophrenia: therapeutic prospects.

Robson PJ. et al, (2014), Curr Pharm Des, 20, 2194 - 2204

Therapeutic potential of cannabinoid medicines

Robson PJ., (2014), Drug Testing and Analysis, 6, 24 - 30

Abuse potential and psychoactive effects of δ-9-tetrahydrocannabinol and cannabidiol oromucosal spray (Sativex), a new cannabinoid medicine

Robson P., (2011), Expert Opinion on Drug Safety, 10, 675 - 685

Cannabis, Pain, and Sleep: Lessons from Therapeutic Clinical Trials of Sativex®, a Cannabis-Based Medicine

Russo EB. et al, (2007), ChemInform, 38

The effects of low doses of delta-9 tetrahydrocannabinol on reinforcement processing in the risky decision-making of young healthy adults.

Rogers RD. et al, (2007), Neuropsychopharmacology, 32, 417 - 428

Effect of sublingual application of cannabinoids on intraocular pressure: A pilot study

Tomida I. et al, (2006), JOURNAL OF GLAUCOMA, 15, 349 - 353

Long-term use of a cannabis-based medicine in the treatment of spasticity and other symptoms in multiple sclerosis

Wade DT. et al, (2006), Multiple Sclerosis Journal, 12, 639 - 645

Safety and tolerability of long-term treatment with a cannabis-based medicine (SATIVEX) in patients with rheumatoid arthritis

Blake DR. et al, (2006), ANNALS OF THE RHEUMATIC DISEASES, 65, 498 - 498

Low doses of delta-9 tetrahydrocannabinol (THC) have divergent effects on short-term spatial memory in young, healthy adults.

Makela P. et al, (2006), Neuropsychopharmacology, 31, 462 - 470

Beyond the end of the line: Case reports of conversion from dextromoramide to other opiates within addiction maintenance treatment

Strang J. et al, (2006), Drugs: Education, Prevention and Policy, 13, 473 - 480

Do cannabis-based medicinal extracts have general or specific effects on symptoms in multiple sclerosis? A double-blind, randomized, placebo-controlled study on 160 patients

Wade DT. et al, (2004), Multiple Sclerosis Journal, 10, 434 - 441

Effect of Delta-9-tetrahydrocannabinol and cannabidiol on nocturnal sleep and early-morning behavior in young adults.

Nicholson AN. et al, (2004), J Clin Psychopharmacol, 24, 305 - 313

A Phase I, Double Blind, Three-Way Crossover Study to Assess the Pharmacokinetic Profile of Cannabis Based Medicine Extract (CBME) Administered Sublingually in Variant Cannabinoid Ratios in Normal Healthy Male Volunteers (GWPK0215)

Guy GW. and Robson PJ., (2004), Journal of Cannabis Therapeutics, 3, 121 - 152

A Phase I, Open Label, Four-Way Crossover Study to Compare the Pharmacokinetic Profiles of a Single Dose of 20 mg of a Cannabis Based Medicine Extract (CBME) Administered on 3 Different Areas of the Buccal Mucosa and to Investigate the Pharmacokinetics of CBME per Oral in Healthy Male and Female Volunteers (GWPK0112)

Guy GW. and Robson PJ., (2004), Journal of Cannabis Therapeutics, 3, 79 - 120

A preliminary controlled study to determine whether whole-plant cannabis extracts can improve intractable neurogenic symptoms

Wade DT. et al, (2003), Clinical Rehabilitation, 17, 21 - 29

Prospects for New Cannabis-Based Prescription Medicines

Whittle BA. et al, (2001), Journal of Cannabis Therapeutics, 1, 183 - 205

Therapeutic aspects of cannabis and cannabinoids

Robson P., (2001), British Journal of Psychiatry, 178, 107 - 115

Patients attending a new drug clinic in 1990 and 1995: characteristics and outcome

Noble F. and Robson PJ., (2000), JOURNAL OF EVALUATION IN CLINICAL PRACTICE, 6, 71 - 74

Load More

Include forthcoming?